Skip to main content
logo
Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.6001
-0.0144 (-2.34%)
Nov 6, 2025, 1:38 PM EST

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had revenue of $40.21M in the quarter ending June 30, 2025, with 113.85% growth. This brings the company's revenue in the last twelve months to $105.45M, up 58.70% year-over-year. In the fiscal year ending March 31, 2025, Elite Pharmaceuticals had annual revenue of $84.04M with 48.42% growth.

Revenue (ttm)
105.45M
Revenue Growth
+58.70%
P/S Ratio
6.26
Revenue / Employee
1.55M
Employees
68
Market Cap
659.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202584.04M27.42M48.42%
Mar 31, 202456.63M22.47M65.79%
Mar 31, 202334.16M1.89M5.87%
Mar 31, 202232.26M6.88M27.11%
Mar 31, 202125.38M7.39M41.05%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings256.36M
Glass House Brands221.55M
Chrome Holding Co.174.90M
Silence Therapeutics27.17M
China New Energy Group Co.12.51M
Nuo Therapeutics2.61M
Revenue Rankings

Elite Pharmaceuticals News

More News